TrialArthritis & rheumatology (Hoboken, N.J.)2014

Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy.

Michelle J Ormseth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.